微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 7.54% | -54.92% | -7.75% | 146/157 | 50.55% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 8.17% | -80.73% | 76.52% | 147/157 | 50.61% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 4.63% | -89.08% | 13.68% | 144/157 | -2.2% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 4.07% | -89.54% | -75.65% | 145/157 | 14.83% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 16.73% | -57.63% | -60.57% | 137/157 | 31.96% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 42.42% | -38.13% | 0% | 95/157 | 51.88% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 42.42% | -40.13% | 8.95% | 92/157 | 22.51% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 38.93% | -45.38% | -1.38% | 100/157 | 33.12% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 39.48% | -39.02% | -42.42% | 95/157 | 51.76% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 68.55% | -10.95% | -3.24% | 36/157 | 51.61% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 70.85% | -10.15% | -0.59% | 33/157 | 32.47% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 71.27% | -13.66% | 10.1% | 35/157 | 38.42% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 64.73% | -25.41% | -15.91% | 42/157 | 52.97% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 76.98% | -13.12% | -2.37% | 28/157 | 53.83% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 78.85% | -12.33% | -4.48% | 24/157 | 5.64% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 82.55% | -8.3% | -4.87% | 19/157 | 20.99% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 86.78% | -9.22% | -2.06% | 11/157 | 54.39% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 88.61% | -2.57% | -1.48% | 12/157 | 55.2% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 89.94% | 2% | -0.1% | 8/157 | 46.77% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 90.02% | 2% | -1.01% | 10/157 | 47.23% | 艾力斯 | 98.7% | 行业排名> |
| 2020-12-31 | 90.94% | 2% | -4.86% | 8/157 | -148.64% | 艾力斯 | 99.4% | 行业排名> |
| 2020-03-31 | 95.59% | 2% | 2% | 1/157 | 55.17% | 首药控股 | 99.94% | 行业排名> |